PHOX2B reliably distinguishes neuroblastoma among small round blue cell tumours. (Q48235413)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28640941%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

title

PHOX2B reliably distinguishes neuroblastoma among small round blue cell tumours (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28640941%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28640941%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Jason L. Hornick

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28640941%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Andrew M Bellizzi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28640941%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

author name string

John P Lee

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28640941%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

publication date

6 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28640941%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28640941%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28640941%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28640941%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

786-794

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28640941%20AND%20SRC:MED&resulttype=core&format=json

Neuroblastoma: biological insights into a clinical enigma

23 March 2020

cites work

1 reference

21 January 2018

1 reference

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report

21 January 2018

1 reference

Mechanisms of neuroblastoma regression

21 January 2018

1 reference

NB84: a new monoclonal antibody for the recognition of neuroblastoma in routinely processed material

21 January 2018

1 reference

Synaptophysin: a marker protein for neuroendocrine cells and neoplasms

21 January 2018

1 reference

Monoclonal antibody NB84 in the differential diagnosis of neuroblastoma and other small round cell tumors.

21 January 2018

1 reference

Olfactory neuroblastoma is not related to the Ewing family of tumors: absence of EWS/FLI1 gene fusion and MIC2 expression.

21 January 2018

1 reference

Clinicopathological and molecular spectrum of ewing sarcomas/PNETs, including validation of EWSR1 rearrangement by conventional and array FISH technique in certain cases

21 January 2018

1 reference

Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall

21 January 2018

1 reference

NUT midline carcinomas of the sinonasal tract

21 January 2018

1 reference

Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases

21 January 2018

1 reference

Limitations in the ability of NB84 to detect metastatic neuroblastoma cells in bone marrow

21 January 2018

1 reference

The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives

21 January 2018

1 reference

PHOX2B immunolabeling: a novel tool for the diagnosis of undifferentiated neuroblastomas among childhood small round blue-cell tumors.

21 January 2018

1 reference

A study of gata3 and phox2b expression in tumors of the autonomic nervous system.

21 January 2018

1 reference

Diagnostic utility of PHOX2B in primary and treated neuroblastoma and in neuroblastoma metastatic to the bone marrow.

21 January 2018

1 reference

Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group.

21 January 2018

1 reference

21 January 2018

Chronic neuroblastoma

1 reference

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

21 January 2018

1 reference

The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report

21 January 2018

1 reference

Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations

21 January 2018

1 reference

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

21 January 2018

1 reference

The genetic landscape of high-risk neuroblastoma

21 January 2018

1 reference

Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes

21 January 2018

1 reference

Oncogenic mutations of ALK kinase in neuroblastoma

21 January 2018

1 reference

Activating mutations in ALK provide a therapeutic target in neuroblastoma

21 January 2018

1 reference

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

21 January 2018

1 reference

Association of age at diagnosis and genetic mutations in patients with neuroblastoma.

21 January 2018

1 reference

Identification of ALK as a major familial neuroblastoma predisposition gene

21 January 2018

1 reference

Germline PHOX2B mutation in hereditary neuroblastoma

21 January 2018

1 reference

Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma

21 January 2018

1 reference

Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome

21 January 2018

1 reference

PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome

21 January 2018

1 reference

Phox2b controls the development of peripheral chemoreceptors and afferent visceral pathways.

21 January 2018

1 reference

PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma

21 January 2018

1 reference

Exploiting gene expression profiling to identify novel minimal residual disease markers of neuroblastoma

21 January 2018

1 reference

Bone marrow minimal residual disease was an early response marker and a consistent independent predictor of survival after anti-GD2 immunotherapy

21 January 2018

1 reference

Methylation-associated PHOX2B gene silencing is a rare event in human neuroblastoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HIS.13288

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28640941%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference